GSB 7.1 Standardlösung

Use of cookies

Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy


Background and goals

Diabetes surveillance aims to provide prompt and periodic reporting on disease dynamics and determinants, quality of care, and secondary diseases.

Diabetes as a public health challenge

Diabetes is a chronic disease with huge public health relevance throughout the world. This particularly applies to type 2 diabetes, which is associated with lifestyles and living conditions. The importance of diabetes is due to the prevalence of type 2 diabetes and its potentially avoidable risk factors. It is often associated with comorbidities and complications, a reduction in health-related quality of life and in healthy  and general life expectancy. As such, the condition is also costly to the health system.

Diabetes surveillance at the Robert Koch Institute

Against this backdrop, the Robert Koch Institute (RKI) is conducting a research project to develop diabetes surveillance in Germany. The project is funded by the Federal Ministry of Health. In the public health context, surveillance refers to the systematic, long-term recording, collection and analysis of health-related data. The aim of diabetes surveillance, therefore, is to establish periodic, indicator-based diabetes reporting to provide prompt and action-oriented information on health policy, health research, health care and public health practices by operationalising the links between data garnered from RKI health monitoring and other relevant sources at the federal and regional levels. The findings should serve as a decision-making aid for planning, implementing and evaluating measures aimed at improving diabetes prevention and care.

The first four-year project phase, ‘Developing National Diabetes Surveillance at the Robert Koch Institute’, aims to achieve the following milestones:

  1. Develop a conceptual framework and define core indicators to measure risk factors, frequency of diabetes, the consequences of the illness and quality of care
  2. Evaluate the available data sources, identify data gaps and assess the integration of secondary data for relevant indicators
  3. Coordinate on the content and format of a periodic national diabetes report that takes international best practices into account
  4. Draw up a prototype National Diabetes Report
  5. Assess how National Diabetes Surveillance can be applied to the surveillance of other chronic diseases

The two-year project phase that follows, ‘Continuation of ongoing project-related funding for diabetes surveillance’, is intended to achieve the following milestones:

  1. Establish and further develop an indicator-based time series through the recurring use and supplementation of the data integrated into the first project phase
  2. Adapt and complement the indicator set in accordance with changing requirements
  3. Strengthen diabetes reporting and ensure that it is geared towards all phases of life and vulnerable target groups
  4. Further link the regionalised results from diabetes surveillance to those from health reporting undertaken at the federal state level
  5. Ensure that the results are made available in a user-friendly and action-oriented manner

Both phases of the project are to be overseen by an interdisciplinary scientific advisory board. In order to ensure that milestones set out above are achieved, the project works with other actors from health policy and public health at the federal and state levels, the Federal Centre for Health Education, professional medical associations and national and international scientific cooperation partners from public health. Furthermore, methodological cooperation projects are also provided with targeted support.